India’s Assistive Technology Market Could Reach ₹95,000 Crore by 2030, Experts Call for National Policy

IMT News Desk
IMT News Desk
· 1 min read
India’s assistive technology market could reach ₹95,000 crore by 2030; NCPEDP and Mphasis are calling for a national policy to expand access and innovation

India’s assistive technology market could grow to as much as ₹95,000 crore by 2030, with experts calling for a dedicated national policy to expand access, affordability and innovation. The push is being backed by NCPEDP, supported by Mphasis, as stakeholders say the sector has both a strong social impact and major economic potential.

NCPEDP said its upcoming policy paper calls for a systems-and-investment approach to build a more inclusive assistive technology ecosystem for persons with disabilities, older adults and people with functional limitations. The paper argues that India needs a comprehensive framework to improve design, delivery, financing and long-term sustainability of assistive solutions.

Experts said the market opportunity could be unlocked through stronger public policy, better standards, local manufacturing and wider adoption of accessible products and services. They added that assistive technology should be treated as essential infrastructure for independence, participation and dignity rather than as a niche product category.

The role of NCPEDP and Mphasis has already extended beyond policy advocacy into startup support and ecosystem building, including the NCPEDP- Mphasis Assistive Technology Hub. The initiative has supported early-stage innovators through seed grants, mentorship and visibility, helping build a pipeline of solutions for accessibility and inclusion.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk